Bone marrow failure and myelofibrosis in a case of PVP storage disease

American Journal of Hematology

Volumn 57, Issue 1, 1998, Pages 68-71

  Dunn, Po ^a   Kuo, Tseng Tong ^a   Shih, Lee Yung ^a   Wang, Po Nan ^a   Sun, Chien Feng ^a   Chang, Ming J W ^b  

^a CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^b CHANG GUNG UNIVERSITY   (Taiwan)

Author keywords

Myelofibrosis; Pathologic fracture; Polyvinylpyrrolidone

Indexed keywords

POVIDONE;

ADULT; ARTHRITIS; ARTICLE; BONE MARROW DEPRESSION; CASE REPORT; CELL PROLIFERATION; FEMALE; HISTIOCYTE; HUMAN; LYMPHOCYTIC INFILTRATION; MYELOFIBROSIS; NUTRITIONAL SUPPORT; PATHOLOGIC FRACTURE; POLYNEUROPATHY; PRIORITY JOURNAL; RETICULOENDOTHELIAL SYSTEM; SPINAL CORD COMPRESSION; STORAGE DISEASE;

ADULT; BONE MARROW; BONE MARROW DISEASES; FEMALE; HUMANS; MYELOFIBROSIS; PLASMA SUBSTITUTES; POVIDONE;

EID: 0031974731     PISSN: 03618609     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-8652(199801)57:1<68::AID-AJH12>3.0.CO;2-5     Document Type: Article

References (12)

1. Ravin HA, Seligman AM, Fine J: Polyvinylpyrrolidone as a plasma expander. Studies on its excretion, distribution and metabolism. N Engl J Med 247:921-929, 1952.
2. Altemeier WA, Schiff L, Gall EA, Giuseffi J, Freiman D, Mindrum G, Braunstein H: Physiological and pathological effects of long-term polyvinylpyrrolidone retension. Arch Surg 69:309-314, 1954.
3. Reske-Nielsen E, Bojsen-Moller M, Vetner M, Hansen JC: Polyvinylpyrrolidone-storage disease. Light microscopical, ultrastructural and chemical verification. Acta Pathol Microbiol Scand Secret A 84:396-405, 1976.
4. Wessel W, Schoog M, Winkler E: Polyvinylpyrrolidone (PVP), its diagnostic, therapeutic and technical application and consequences thereof. Arzneimittel forschung (Drug Res) 21:1468-1482, 1971.
5. Rubis JJ, Cohen S, Dinbar J, Hirschhorn B, Szeinberg A, Wolman M: Storage of polyvinylpyrrolidone mimicking a congenital mucolipid storage disease in a patient with Munchausen's syndrome. Isr J Med Sci 11:999-1004, 1975.
6. Christensen M, Johansen P, Hau C: Storage of polyvinylpyrrolidone (PVP) in tissues following long-term treatment with a PVP-containing vasopressin preparation. Acta Med Scand 204:295-298, 1978.
7. Takahashi K, Eto K, Takeya M, Naito M, Yaginuma Y, Ichihara A: Long-term polyvinylpyrrolidone storage. Histochemical and ultrastructural observations in two biopsy cases. Acta Pathol Jpn 33:985-997, 1983.
8. Kepes JJ, Chen WYK, Jim YF: "Mucoid dissolution" of bones and multiple pathologic fractures in a patient with past history of intravenous administration of polyvinylpyrrolidone (PVP). A case report. Bone Mineral 22:33-41, 1993.
9. Kuo T, Hsueh S: Mucicarminophilic histiocytosis. A polyvinylpyrrolidone (PVP) storage disease simulating signet-ring cell carcinoma. Am J Surg Pathol 8:419-428, 1984.
10. Chen WYK, Kepes JJ, Teglbjaerg PS: Intracellular mucoid changes in tumor cells of meningiomas: A manifestation of polyvinylpyrrolidone (PVP) effect on tissues with mesenchymal characteristics. J Neuropathol Exp Neurol 44:606-612, 1985.
11. McCarthy DM: Fibrosis of the bone marrow: Content and causes. Br J Haematol 59:1-7, 1985.
12. Tondel M, Persson B, Carstensen J: Myelofibrosis and benzene exposure. Occup Med 45:51-52, 1995.